基于技术的替代疗法的未来:关于便携式,可穿戴式和可植入式人工的最新情况

Fokko P Wieringa1, Swathi Suran2, Henning Søndergaard3

  • 1imec, Holst Centre, Eindhoven, The Netherlands; Department of Nephrology, University Medical Center Utrecht, Utrecht, The Netherlands; European Kidney Health Alliance Work Group 3 "Breakthrough Innovation," Brussels, Belgium; International Electrotechnical Commission TC62D/MT20, Geneva, Switzerland.

概括

数以百万计的需要置换疗法 (KRT) 的患者无法获得. 移动透析和生物反应器等创新可以提高KRT的可访问性和可负担性,克服基础设施障碍.